Skip to content
Screener

Assembly Biosciences ASMB Q1 2025 earnings

Reported May 8, 2025 · Before market open

Revenue$9.4MBeat by $2.0M
EPS-$1.17Beat by $0.84
Revenue estimate$7.4M
EPS estimate-$2.01

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$9.1M
EPS estimate-$0.66

Financials

Q1 2025

Income statement

See full
Revenue$9.4M+62.8%
Operating income-$9.9M+7.3%
Net income-$8.8M+2.9%
EPS (diluted)-$1.17+29.5%

Balance sheet

See full
Cash & equivalents$23.4M+24.9%
Total debt$3.0M+56.0%
Total equity$27.1M-16.8%
Total assets$99.0M-17.4%

Cash flow

See full
Operating cash flow-$23.4M-27.6%
CapEx--100%
Free cash flow-$23.4M-27.5%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$71.73M-1.6%
Enterprise value$51.34M-8.5%
P/S2.2×-3.4×

Profitability

See full
Operating margin-138.8%-56.1pp
Net margin-124.1%-50.6pp
FCF margin-174.8%-387pp

Returns & leverage

See full
Return on equity-133.7%+68.7pp
Debt / equity0.1×+0.1×
Current ratio2×-1.0×

FAQ

When did Assembly Biosciences report Q1 2025 earnings?
Assembly Biosciences (ASMB) reported Q1 2025 earnings on May 8, 2025 before market open.
What were Assembly Biosciences's Q1 2025 revenue and EPS?
Assembly Biosciences reported revenue of $9.4M and eps of $-1.17 for Q1 2025.
Did Assembly Biosciences beat estimates in Q1 2025?
Revenue beat the consensus estimate of $7.4M by $2.0M. EPS beat the consensus estimate of $-2.01 by $0.84.
How did Assembly Biosciences's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 62.8% from $5.8M a year earlier and eps grew 29.5% from $-1.66.
Where can I find Assembly Biosciences's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-066946) and the 10-Q periodic report (0000950170-25-066991) directly on SEC EDGAR. The filing index links above go to sec.gov.